Browse By Cell Line Result Page of OvirusTdb

The total number of records retrieved from this search are 25. Click on ID to see further detail.
IDVirus nameVirus strainVirus genome typeVirus familyVirus genome modificationVirus aloneVirus in combination with drug/radiationImmune gene insertion in viral genomeSource of cell lineOrigin of cell lineCell lineConcentration of cell lineIn-vitro toxicityAssayIn-vitro virus concentrationIn-vitro resultModel organismIn-vivo virus concentrationIn-vivo toxicityIn-vivo resultMode of deliveryPathway inducedImmunogenic effectClinical trialPMID
OV_1449ReovirusReoT3DRNAReoviridaeNoneYesNoNoNCIHuman NSCLC cell lineNCI-H23NANAXTT assayLog10 pfu/cell20% cell survived 48 hours after post infectionNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1455ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (0.08 +/- 0.04 micromolar, 1:20)NoNCIHuman NSCLC cell lineNCI-H23NANAchou-Talay analysisLog10 pfu/cell50% cell death occurs at 0.577 CI valueNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1461ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (0.08 +/- 0.04 micromolar, 1:20)NoNCIHuman NSCLC cell lineNCI-H23NANAchou-Talay analysisLog10 pfu/cell75% cell death at CI value 0.303NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1467ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (0.08 +/- 0.04 micromolar, 1:20)NoNCIHuman NSCLC cell lineNCI-H23NANAchou-Talay analysisLog10 pfu/cell90% cell death at CI value 0.159NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1473ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (0.08 +/- 0.04 micromolar, 1:200)NoNCIHuman NSCLC cell lineNCI-H23NANAchou-Talay analysisLog10 pfu/cell50% cell death occurs at 0.329 CI valueNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1479ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (0.08 +/- 0.04 micromolar, 1:200)NoNCIHuman NSCLC cell lineNCI-H23NANAchou-Talay analysisLog10 pfu/cell75% cell death at CI value 0.061NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1485ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with palcitaxel (0.08 +/- 0.04 micromolar, 1:200)NoNCIHuman NSCLC cell lineNCI-H23NANAchou-Talay analysisLog10 pfu/cell90% cell death at CI value 0.011NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1491ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (3.51+/- 1.15, ratio is 1:20)NoNCIHuman NSCLC cell lineNCI-H23NANAchou-Talay analysisLog10 pfu/cell50% cell death at CI value 0.579NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1497ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (3.51+/- 1.15, ratio is 1:20)NoNCIHuman NSCLC cell lineNCI-H23NANAchou-Talay analysisLog10 pfu/cell75% death at CI value 0.487NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1503ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (3.51+/- 1.15, ratio is 1:20)NoNCIHuman NSCLC cell lineNCI-H23NANAchou-Talay analysisLog10 pfu/cell90% cell death at CI value 0.530NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1509ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (3.51+/- 1.15, ratio is 1:200)NoNCIHuman NSCLC cell lineNCI-H23NANAchou-Talay analysisLog10 pfu/cell50% cell death at CI value 0.546NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1515ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (3.51+/- 1.15, ratio is 1:200)NoNCIHuman NSCLC cell lineNCI-H23NANAchou-Talay analysisLog10 pfu/cell75% death at CI value 0.207NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1521ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with cisplatin (3.51+/- 1.15, ratio is 1:200)NoNCIHuman NSCLC cell lineNCI-H23NANAchou-Talay analysisLog10 pfu/cell90% cell death at CI value 0.342NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1527ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (0.02+/- 0.01, 1:20)NoNCIHuman NSCLC cell lineNCI-H23NANAchou-Talay analysisLog10 pfu/cell50% cell death at CI value 0.630NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1533ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (0.02+/- 0.01, 1:20)NoNCIHuman NSCLC cell lineNCI-H23NANAchou-Talay analysisLog10 pfu/cell75 % cell death at CI 0.249NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1539ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (0.02+/- 0.01, 1:20)NoNCIHuman NSCLC cell lineNCI-H23NANAchou-Talay analysisLog10 pfu/cell90% cell killing at CI 0.285NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1545ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (0.02+/- 0.01, 1:200)NoNCIHuman NSCLC cell lineNCI-H23NANAchou-Talay analysisLog10 pfu/cell50% cell killing at CI 0.207NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1551ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (0.02+/- 0.01, 1:200)NoNCIHuman NSCLC cell lineNCI-H23NANAchou-Talay analysisLog10 pfu/cell75% cell killing at CI 0.092NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1557ReovirusReoT3DRNAReoviridaeNoneNoVirus in combination with Gemcitabine (0.02+/- 0.01, 1:200)NoNCIHuman NSCLC cell lineNCI-H23NANAchou-Talay analysisLog10 pfu/cell90% cell killing at CI 0.369NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1563ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(1.49+/-1.09nm, 1:2)NoNCIHuman NSCLC cell lineNCI-H23NANAchou-Talay analysisLog10 pfu/cell50% cell killing at CI 0.316NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1569ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(1.49+/-1.09nm, 1:2)NoNCIHuman NSCLC cell lineNCI-H23NANAchou-Talay analysisLog10 pfu/cell75% cell killing at CI 0.056NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1575ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(1.49+/-1.09nm, 1:2)NoNCIHuman NSCLC cell lineNCI-H23NANAchou-Talay analysisLog10 pfu/cell90% cell killing at CI 0.019NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1581ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(1.49+/-1.09nm, 1:20)NoNCIHuman NSCLC cell lineNCI-H23NANAchou-Talay analysisLog10 pfu/cell50% cell killing at CI 0.367NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1587ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(1.49+/-1.09nm, 1:20)NoNCIHuman NSCLC cell lineNCI-H23NANAchou-Talay analysisLog10 pfu/cell75% cell killing at CI 0.052NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950
OV_1593ReovirusReoT3DRNAReoviridaeNoneNoVirus combination with vinblastine(1.49+/-1.09nm, 1:20)NoNCIHuman NSCLC cell lineNCI-H23NANAchou-Talay analysisLog10 pfu/cell90% cell killing at CI 0.008NoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19594950